Direct action antivirals are effective in the total eradication of HCV in renal transplants

<p><strong>Introduction</strong>: The main objective of our study was to analyze the effectiveness of antiviral treatment (conventional or with direct-acting antivirals (DAA)) for total eradication of Hepatitis C Virus (HCV) in kidney transplant (KT) recipients. DAA are known drugs...

Full description

Saved in:
Bibliographic Details
Main Authors: Teresa Olea (Author), Inmaculada Castillo (Author), Carlos Jiménez (Author), Javier Bartolomé (Author), María José Santana (Author), JA Quiroga (Author), Vicente Carreño (Author), Rafael Selgas (Author)
Format: Book
Published: Annals of Antivirals and Antiretrovirals - Peertechz Publications, 2019-07-22.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_aaa_000005
042 |a dc 
100 1 0 |a Teresa Olea  |e author 
700 1 0 |a  Inmaculada Castillo  |e author 
700 1 0 |a  Carlos Jiménez  |e author 
700 1 0 |a  Javier Bartolomé  |e author 
700 1 0 |a  María José Santana  |e author 
700 1 0 |a  JA Quiroga  |e author 
700 1 0 |a  Vicente Carreño  |e author 
700 1 0 |a Rafael Selgas  |e author 
245 0 0 |a Direct action antivirals are effective in the total eradication of HCV in renal transplants 
260 |b Annals of Antivirals and Antiretrovirals - Peertechz Publications,   |c 2019-07-22. 
520 |a <p><strong>Introduction</strong>: The main objective of our study was to analyze the effectiveness of antiviral treatment (conventional or with direct-acting antivirals (DAA)) for total eradication of Hepatitis C Virus (HCV) in kidney transplant (KT) recipients. DAA are known drugs that are approved by FDA for clinical and preclinical</p><p>investigations. The effi cacy was analyzed by testing for the presence of HCV- ribonucleic acid (RNA) in the pellets obtained after ultracentrifugation of follow-up plasma samples and in peripheral blood mononuclear cells (PBMC) from patients with HCV infection who had achieved a sustained virological response (SVR). The safety, and the renal and hepatic repercussions of the antiviral treatment were also evaluated.</p> 
540 |a Copyright © Teresa Olea et al. 
546 |a en 
655 7 |a Research Article  |2 local 
856 4 1 |u https://doi.org/10.17352/aaa.000005  |z Connect to this object online.